T202-0841 Screening compound: 2-(3,4-dimethoxyphenyl)-5-[(2-fluorophenyl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine

T202-0841 Screening compound: 2-(3,4-dimethoxyphenyl)-5-[(2-fluorophenyl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine
T202-0841 Screening compound: 2-(3,4-dimethoxyphenyl)-5-[(2-fluorophenyl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine alternative view

Chemical Structure Depiction of ChemDiv screening compound T202-0841
2-(3,4-dimethoxyphenyl)-5-[(2-fluorophenyl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T202-0841

Molecular Formula

C22H24FN3O2 (C22 H24 FN3 O2)

Compound Name

2-(3,4-dimethoxyphenyl)-5-[(2-fluorophenyl)methyl]-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine

IUPAC name

2-(34-dimethoxyphenyl)-5-[(2-fluorophenyl)methyl]-4H5H6H7H8H-pyrazolo[15-a][14]diazepine

SMILES

COc(ccc(-c1nn(CCCN(Cc(cccc2)c2F)C2)c2c1)c1)c1OC

InChI

InChI=1S/C22H24FN3O2/c1-27-21-9-8-16(12-22(21)28-2)20-13-18-15-25(10-5-11-26(18)24-20)14-17-6-3-4-7-19(17)23/h3-4,6-9,12-13H,5,10-11,14-15H2,1-2H3

InChI Key

NVRQFGQGPRIFAH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27618720

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

381.45

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.579

Distribution Coefficient, logD

3.538

Water Solubility, LogSw

-3.60

Polar Surface Area

32.762

Acid Dissociation Constant (pKa)

26.76

Base Dissociation Constant (pKb)

6.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

T202-0841 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with T202-0841 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T202-0841?
Check Price and Availability of T202-0841, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T202-0841 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T202-0841
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T202-0841
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T202-0841 available by request